Incannex Healthcare (IXHL) Competitors $0.59 0.00 (-0.02%) Closing price 04:00 PM EasternExtended Trading$0.61 +0.01 (+2.03%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. PRLD, ADVM, VTVT, ALGS, COEP, ARTV, CELU, APLT, IMMX, and MNOVShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Prelude Therapeutics (PRLD), Adverum Biotechnologies (ADVM), vTv Therapeutics (VTVT), Aligos Therapeutics (ALGS), Coeptis Therapeutics (COEP), Artiva Biotherapeutics (ARTV), Celularity (CELU), Applied Therapeutics (APLT), Immix Biopharma (IMMX), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Its Competitors Prelude Therapeutics Adverum Biotechnologies vTv Therapeutics Aligos Therapeutics Coeptis Therapeutics Artiva Biotherapeutics Celularity Applied Therapeutics Immix Biopharma MediciNova Prelude Therapeutics (NASDAQ:PRLD) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Which has more volatility and risk, PRLD or IXHL? Prelude Therapeutics has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.66, suggesting that its stock price is 666% more volatile than the S&P 500. Does the media favor PRLD or IXHL? In the previous week, Prelude Therapeutics had 12 more articles in the media than Incannex Healthcare. MarketBeat recorded 13 mentions for Prelude Therapeutics and 1 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 1.91 beat Prelude Therapeutics' score of 1.01 indicating that Incannex Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Prelude Therapeutics Positive Incannex Healthcare Very Positive Do analysts prefer PRLD or IXHL? Prelude Therapeutics currently has a consensus target price of $4.00, indicating a potential upside of 166.67%. Given Prelude Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Prelude Therapeutics is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prelude Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in PRLD or IXHL? 79.7% of Prelude Therapeutics shares are owned by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are owned by institutional investors. 63.9% of Prelude Therapeutics shares are owned by insiders. Comparatively, 15.5% of Incannex Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is PRLD or IXHL more profitable? Prelude Therapeutics' return on equity of -106.50% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Prelude TherapeuticsN/A -106.50% -79.07% Incannex Healthcare N/A -342.92%-148.64% Which has preferable valuation and earnings, PRLD or IXHL? Incannex Healthcare has lower revenue, but higher earnings than Prelude Therapeutics. Prelude Therapeutics is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrelude Therapeutics$7M12.13-$127.17M-$1.64-0.91Incannex Healthcare$10K1,750.79-$18.46M-$1.21-0.49 SummaryPrelude Therapeutics beats Incannex Healthcare on 9 of the 15 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.51M$2.50B$5.66B$10.37BDividend YieldN/A54.21%5.75%4.64%P/E Ratio-0.4923.8175.8226.15Price / Sales1,750.79725.93560.95125.53Price / CashN/A176.2437.6061.28Price / Book3.315.1712.416.36Net Income-$18.46M$32.95M$3.29B$270.97M7 Day Performance13.42%2.40%1.26%0.36%1 Month Performance-16.19%6.29%3.84%6.37%1 Year Performance-70.84%2.15%61.01%28.46% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.4198 of 5 stars$0.590.0%N/A-70.5%$17.51M$10K-0.493Positive NewsUpcoming EarningsPRLDPrelude Therapeutics3.4368 of 5 stars$1.13-6.6%$4.00+254.0%-41.3%$63.96M$7M-0.69120News CoveragePositive NewsAnalyst ForecastAnalyst RevisionADVMAdverum Biotechnologies3.6992 of 5 stars$3.02-3.8%$19.75+554.0%-34.6%$63.37M$1M-0.38190Analyst ForecastGap DownVTVTvTv Therapeutics2.6917 of 5 stars$19.84-1.1%$35.50+78.9%+71.2%$63.29M$1.02M-6.369Gap DownALGSAligos Therapeutics3.861 of 5 stars$10.20-6.3%$50.00+390.2%+13.9%$62.73M$3.94M-0.5290COEPCoeptis Therapeutics0.4636 of 5 stars$13.01+4.7%N/A+397.9%$62.71M$263.56K-2.242ARTVArtiva Biotherapeutics3.2271 of 5 stars$2.55-4.1%$17.00+566.7%-80.1%$62.30M$250K0.0081Positive NewsCELUCelularity1.8913 of 5 stars$2.32-0.4%$6.00+158.6%-29.7%$61.92M$54.22M-0.73220APLTApplied Therapeutics3.8218 of 5 stars$0.42-4.7%$6.10+1,350.3%-93.3%$60.57M$460K-0.9330News CoveragePositive NewsGap UpIMMXImmix Biopharma3.1099 of 5 stars$2.10-5.4%$8.00+281.0%+23.6%$60.54MN/A-2.739MNOVMediciNova1.9873 of 5 stars$1.23-1.6%$7.00+469.1%-38.6%$60.33M$134.60K-4.9210Gap Up Related Companies and Tools Related Companies Prelude Therapeutics Alternatives Adverum Biotechnologies Alternatives vTv Therapeutics Alternatives Aligos Therapeutics Alternatives Coeptis Therapeutics Alternatives Artiva Biotherapeutics Alternatives Celularity Alternatives Applied Therapeutics Alternatives Immix Biopharma Alternatives MediciNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IXHL Stock Alerts